Sue MacLeman

Sue MacLeman has more than 25 years’ experience as a pharmaceutical, biotechnology and medical technology executive. She has held roles in corporate, medical, commercial and business development at Schering-Plough Corporation (now Merck), Amgen, Bristol-Myers Squibb and Mesoblast Ltd.

Sue has also served as CEO and Board Member of several ASX and NASDAQ listed companies in the sector and is currently a Non-Executive Director at Reproductive Health Sciences Ltd and Oventus Medical Ltd.